Enable Injections Announces $30 Million Investment from Sanofi to Accelerate Manufacturing Capabilities

Enable Injections, Inc. (“Enable”) a healthcare innovation company developing and manufacturing the enFuse ® On-Body Delivery System (OBDS), announced today that Sanofi is making a $30 million ...
FierceBiotech

Enable Injections, Incyte ink drug delivery collab focused on chronic blood, bone marrow conditions

Enable Injections, maker of the enFuse wearable drug delivery system, inked a partnership deal with Incyte to join the companies' technologies in a bid to advance patient care in certain diseases. The ...
Business Wire

Enable Raises $94M Series C to Catalyze the Rapid Growth of the Rebate Management Category

SAN FRANCISCO--(BUSINESS WIRE)--Enable, the collaborative rebate management platform, today announced that it has raised an oversubscribed $94 million Series C financing round. The round, which brings ...
Drug Delivery Business

Enable Injections picks up $30M investment from Sanofi

Enable Injections announced today that it received a commitment from Sanofi for a $30 million investment to drive growth.